University College London: CAR T-cell Therapy Shows Early Promise in Severe Lupus
June 12, 2026
June 12, 2026
LONDON, England, June 12 -- The University College London posted the following news:
* * *
CAR T-cell therapy shows early promise in severe lupus
Early results from a UCL and UCLH-led clinical trial suggest that a type of CAR T-cell therapy - developed by Autolus Therapeutics, a UCL spinout - could offer a new treatment approach for people with severe, treatment-resistant lupus.
The findings, presented at the EULAR European Congress of Rheumato . . .
* * *
CAR T-cell therapy shows early promise in severe lupus
Early results from a UCL and UCLH-led clinical trial suggest that a type of CAR T-cell therapy - developed by Autolus Therapeutics, a UCL spinout - could offer a new treatment approach for people with severe, treatment-resistant lupus.
The findings, presented at the EULAR European Congress of Rheumato . . .